
"Effectiveness of Higher-Dose Naloxone in Opioid Overdose Response: Study Findings"
A study compared the administration of 8-milligram and 4-milligram intranasal naloxone by law enforcement during responses to suspected opioid overdoses in New York from March 2022 to August 2023. The study found no significant differences in survival or the number of doses administered between the two formulations, but recipients of the 8-milligram product had a higher prevalence of opioid withdrawal signs and symptoms, including vomiting, compared to those who received the 4-milligram product. The findings suggest that there are no benefits to law enforcement administration of higher-dose naloxone, and more data are needed to determine whether the 8-milligram intranasal naloxone provides added benefits.

